Search

Your search keyword '"Oromendia C"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Oromendia C" Remove constraint Author: "Oromendia C"
66 results on '"Oromendia C"'

Search Results

2. Attributable Mortality of Acute Respiratory Distress Syndrome in Critically Ill Septic Patients: Estimation Using a Novel Causal Inference Method

3. A Symptom-Based Approach to Defining Exacerbations Suggests High Burden of Exacerbation Events in SPIROMICS

5. Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy

6. The Necroptosis Endotype in Neutropenic Critical Illness

8. An Analysis of the Respiratory Subscore of the Sequential Organ Failure Assessment (SOFA) Scoring System in the Weill Cornell-Critical Care Database for Advanced Research (WC-CEDAR)

10. Phase I dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration resistant prostate cancer (mCRPC)

12. A phase 2 study of the aurora kinase A inhibitor alisertib for patients with neuroendocrine prostate cancer (NEPC)

18. Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.

19. Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis.

20. The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.

21. Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument.

22. Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation.

23. A Comparative Analysis of the Respiratory Subscore of the Sequential Organ Failure Assessment Scoring System.

24. Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors.

25. Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.

26. Effect of Neutropenic Critical Illness on Development and Prognosis of Acute Respiratory Distress Syndrome.

27. Increased platelet activation in sleep apnea subjects with intermittent hypoxemia.

28. Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS.

29. Prognostic value of the SPOP mutant genomic subclass in prostate cancer.

30. Alveolar Macrophage Immunometabolism and Lung Function Impairment in Smoking and Chronic Obstructive Pulmonary Disease.

31. Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort.

32. Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case series.

33. Persistent severe acute respiratory distress syndrome for the prognostic enrichment of trials.

34. Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series.

35. Clinical features of neuroendocrine prostate cancer.

36. Paired Associative Stimulation as a Tool to Assess Plasticity Enhancers in Chronic Stroke.

37. Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience.

38. Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis.

39. Retrospective single-center study evaluating clinical and dermoscopic features of longitudinal melanonychia, ABCDEF criteria, and risk of malignancy.

40. To Code or Not To Code: Teaching Multidisciplinary Clinicians to Conduct Code Status Discussions.

41. Rapidly Improving ARDS in Therapeutic Randomized Controlled Trials.

42. Automated expiratory ventilation assistance through a small endotracheal tube can improve venous return and cardiac output.

43. Clinical improvement with intensive robot-assisted arm training in chronic stroke is unchanged by supplementary tDCS.

44. Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn's Disease Patients.

45. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.

46. A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS.

47. Robotic Arm Rehabilitation in Chronic Stroke Patients With Aphasia May Promote Speech and Language Recovery (but Effect Is Not Enhanced by Supplementary tDCS).

48. Acute respiratory distress syndrome without identifiable risk factors: A secondary analysis of the ARDS network trials.

49. Reclassification of Acute Respiratory Distress Syndrome: A Secondary Analysis of the ARDS Network Trials.

50. Circulating RIPK3 levels are associated with mortality and organ failure during critical illness.

Catalog

Books, media, physical & digital resources